比推消息,法拉第未来 (NASDAQ: FFAI) 今日宣布,将通过 4100 万美元 PIPE 交易战略投资 Qualigen Therapeutics(NASDAQ: QLGN),后者将更名为 CXC10,转型为加密和 Web3 业务平台。
比推消息,法拉第未来 (NASDAQ: FFAI) 今日宣布,将通过 4100 万美元 PIPE 交易战略投资 Qualigen Therapeutics(NASDAQ: QLGN),后者将更名为 CXC10,转型为加密和 Web3 业务平台。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.